All News
🟢 TCAI is trading 2.55% up in pre-market; rebound catalyst unclear
TCAI is trading at $38.99, up +2.55% versus the previous close, with no clear catalyst identified for its pre-market rise. - The October 22 semi-annual report...
🟢 Ideaya Biosciences is trading 8% up in pre-market after IDE849 data showed promising anti-tumor activity
Ideaya Biosciences is trading at $39.00, up +7.97%, in pre-market on October 23, 2026, amid updated IDE849 clinical results, the clearest available...
Rocket Lab Launches 98th Electron Mission; Shares Rise 2%
Rocket Lab USA, Inc. completed its 98th Electron mission with a dedicated flight for signals-intelligence company HawkEye 360. The mission, named “We’re Not...
🔴 Grupo Televisa is trading 8.32% down in pre-market with no confirmed overnight company-specific catalyst
Grupo Televisa is trading at $2.19, down 8.32% in pre-market, with no confirmed overnight company-specific catalyst identified. - The October 22 close was...
🟢 SMHX is trading 2.36% up in pre-market as semiconductor stocks rebound after Thursday’s sell-off
SMHX is trading at $53.42, up 2.36% in pre-market as semiconductor stocks rebound after Thursday’s sharp sell-off. - Thursday’s losses reflected concerns...
Google Launches $150,000 AI Competition to Tackle Quantum Computing Challenges
Alphabet Inc.'s Google has launched a competition with a $150,000 prize pool. It challenges participants to use AI to enhance quantum computation...
🟢 LAZR is trading 11.47% up in pre-market with no identified catalyst
LAZR is trading 11.47% higher at $37.27 in pre-market, with no clear LAZR-specific announcement or catalyst identified. - LAZR closed at $33.44 on October...
🟢 Opus Genetics is trading 6% up in pre-market with no clear company-specific catalyst
Opus Genetics is trading 5.67% higher at $4.04 in pre-market on October 23, with no clear company-specific catalyst identified. - Compared with the October 22...
Stock Extends Winning Streak to 9 Days; Nisa Investment Advisors Increases Stake
Cognizant Technology Solutions Corp. marked a nine-day winning streak. The company added approximately $6.8 billion to its market value. Its stock surged 24.5%...
🟢 Tech ETF (CHPS) is trading 1.82% up in pre-market as chipmakers stage selective rebound
CHPS is trading at $76.23, up 1.82%, amid signs of a selective semiconductor rebound. - After October 22’s tech selloff, pre-market sentiment was mixed:...
🟢 Shift4 Payments is trading 7.1% up in pre-market
Shift4 Payments is trading at $43.00, up 7.05% in pre-market, with no clear catalyst identified for the move. - After the October 22 close, Shift4 announced...
🟢 DSL is trading 3.38% up in pre-market; catalyst remains unclear
DSL is trading at $10.10, up 3.38% in pre-market, with the catalyst unclear. - No company-specific announcement explaining the October 23 pre-market rise was...
🟢 Cerenome is trading 5.7% up in pre-market — catalyst remains unclear
Cerenome is trading at $1.85, up +5.71%, with no confirmed catalyst for the pre-market move. - No fresh company announcement dated October 23, 2026, was...
🔴 Natural Gas ETF (BOIL) is trading 3.05% down in pre-market as mild forecasts curb heating demand
BOIL is trading at $17.53 (-3.05%) as mild U.S. weather forecasts into early November curb expected heating demand and weigh on natural gas futures. -...
🟢 ARTY is trading 1.56% up in pre-market
ARTY is trading at $69.94, up 1.56% pre-market, with no new ARTY-specific announcement or clear catalyst identified for the move. - The prior-session...
🟢 Immix Biopharma is trading 8% up in pre-market with no clear company-specific catalyst
Immix Biopharma is trading at $9.00, up +7.78%, before the October 23, 2026 open, with no clear company-specific announcement tied to the move. - The latest...
Rithm Capital's third quarter 2026 revenue of $1.76B beat estimates while book value expanded
Rithm Capital reported third quarter 2026 results that exceeded top-line expectations, supported by scaling its alternative asset management platform and...
🔴 BioLineRx is trading 6.7% down in pre-market
BioLineRx is trading 6.7% down at $1.95 in pre-market, with no clear company-specific announcement identified as the reason. - The company’s...
Balchem Corporation reports record third quarter 2026 sales of $291M with growth in all segments
Balchem Corporation achieved record consolidated net sales and earnings for the third quarter of 2026, supported by organic growth across its entire portfolio....
Xencor's Kidney Cancer Drug Gets Its Biggest Test Yet — Can Early Data Justify a Stock That Has Already Doubled?
Shares surged +8.4% to $28.00 as Xencor's most important clinical catalyst arrived: early-stage trial results for its experimental kidney cancer drug, a...